Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) saw an upside of 5.88% to close Tuesday at $2.34 after adding $0.13 on the day. The 5-day average trading volume is 1,887,820 shares of the company’s common stock. It has gained $2.34 in the past week. An average of 2,617,725 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,075,028.
MNMD’s 1-month performance is -2.09% or -$0.18 on its low of $2.16 reached on 10/06/21. The company’s shares have touched a 52-week low of $0.72 and high of $5.77, with the stock’s rally to the 52-week high happening on 04/27/21. YTD, MNMD has lost -23.28% or -$0.71. However, the current price is down -59.45%% from the 52-week high price.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
Mind Medicine (MindMed) Inc. (MNMD) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.19 for the sector.MNMD stock has a beta of 0.00.
For the quarterly period ending December 30 this year, Analysts expected MNMD to announce -$0.02 per share in earnings in its latest quarter, but it posted -$0.01, representing a 50.00% surprise. MNMD stock balance sheet for the quarter ending December 30 shows that total liabilities totaled 17.47 million
Let’s look briefly at Mind Medicine (MindMed) Inc. (MNMD) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 49.64% to suggest the stock is trending Neutral, with historical volatility in this time period at 47.64%.
The stock’s 5-day moving average is $2.25, reflecting a +4.00% or $0.09 change from its current price. MNMD is currently trading +2.18% above its 20-day SMA, -38.42% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -23.78% and -22.26% respectively.
Stochastic %K and %D was 24.60% and 19.31% and the average true range (ATR) pointed at 0.11. The RSI (14) points at 44.61%, while the 14-day stochastic is at 42.86% with the period’s ATR at 0.12. The stock’s 9-day MACD Oscillator is pointing at 0.00 and -0.07 on the 14-day charts.
In the most recent analyst report for Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), Maxim Group launched coverage with a Buy rating. Analysts offering their rating for MNMD stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate MNMD as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is MNMD’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $3.38 and a high of $7.92, with their median price target at $5.14. Looking at these predictions, the average price target given by analysts is for Mind Medicine (MindMed) Inc. (MNMD) stock is $5.48.